Transaction DateRecipientSharesTypePriceValue
20th October 2020Holdings A/S Novo2,414,563Conversion of derivative$0.00
20th October 2020Holdings A/S Novo150,000Open or private purchase$18.00$2,700,000.00
20th October 2020Holdings A/S Novo737,071Conversion of derivative$0.00
20th October 2020Holdings A/S Novo200,000Open or private purchase$15.00$3,000,000.00
20th October 2020Holdings A/S Novo2,442,080Conversion of derivative$0.00
15th October 2020Holdings A/S Novo450,000Open or private sale$11.00$4,950,000.00
14th October 2020Holdings A/S Novo250,000Open or private purchase$15.00$3,750,000.00
14th October 2020Holdings A/S Novo4,739,336Conversion of derivative$0.00
18th September 2020Investments, Lp Rtw750,000Open or private purchase$17.00$12,750,000.00
18th September 2020Investments, Lp Rtw1,535,131Conversion of derivative$0.00
Milestone Pharmaceuticals
Milestone Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Milestone Pharmaceuticals, Inc. is a biopharmaceutical company. It designs and develops a rapid-onset nasal spray with Etripamil.

Ticker: MIST
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1408443
Employees: 30
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags